Progesterone antagonists such as CDB-4124 in the treatment of breast cancer

Details for Australian Patent Application No. 2009241360 (hide)

Owner Repros Therapeutics Inc.

Inventors Wiehle, Ronald D.; Podolski, Joseph S.

Agent Wrays

Pub. Number AU-B-2009241360

PCT Pub. Number WO2009/134723

Priority 61/048,452 28.04.08 US

Filing date 27 April 2009

Wipo publication date 5 November 2009

Acceptance publication date 8 March 2012

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/134723 Priority application(s): WO2009/134723

8 March 2012 Application Accepted

  Published as AU-B-2009241360

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009241365-Compositions and methods for treating multiple sclerosis

2009241355-Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc